[HTML][HTML] Exosomes in the tumor microenvironment: From biology to clinical applications
VR da Costa, RP Araldi, H Vigerelli, F D'Ámelio… - Cells, 2021 - mdpi.com
Cancer is one of the most important health problems and the second leading cause of death
worldwide. Despite the advances in oncology, cancer heterogeneity remains challenging to …
worldwide. Despite the advances in oncology, cancer heterogeneity remains challenging to …
[HTML][HTML] ALDH1: A potential therapeutic target for cancer stem cells in solid tumors
Y Wei, Y Li, Y Chen, P Liu, S Huang, Y Zhang… - Frontiers in …, 2022 - frontiersin.org
Solid tumors can be divided into benign solid tumors and malignant solid tumors in the
academic community, among which malignant solid tumors are called cancers. Cancer is …
academic community, among which malignant solid tumors are called cancers. Cancer is …
Interplay between EZH2/β-catenin in stemness of cisplatin-resistant HNSCC and their role as therapeutic targets
TM Milan, APE Eskenazi, LD de Oliveira, G da Silva… - Cellular …, 2023 - Elsevier
The Wnt/β-catenin signaling pathway is associated with the regulation of cancer stem cells,
and it can be driven by epigenetic modifications. Here, we aim to identify epigenetic …
and it can be driven by epigenetic modifications. Here, we aim to identify epigenetic …
[HTML][HTML] Adherens junction proteins on the move—From the membrane to the nucleus in intestinal diseases
LR Lessey, SC Robinson, R Chaudhary… - Frontiers in Cell and …, 2022 - frontiersin.org
The function and structure of the mammalian epithelial cell layer is maintained by distinct
intercellular adhesion complexes including adherens junctions (AJs), tight junctions, and …
intercellular adhesion complexes including adherens junctions (AJs), tight junctions, and …
[HTML][HTML] Integrated whole transcriptome profiling revealed a convoluted circular RNA-based competing endogenous RNAs regulatory network in colorectal cancer
H Mollanoori, Y Ghelmani, B Hassani, M Dehghani - Scientific Reports, 2024 - nature.com
Recently, it has been identified that circRNAs can act as miRNA sponge to regulate gene
expression in various types of cancers, associating them with cancer initiation and …
expression in various types of cancers, associating them with cancer initiation and …
nuPRISM: Microfluidic Genome-Wide Phenotypic Screening Platform for Cellular Nuclei
Genome-wide loss-of-function screens are critical tools to identify novel genetic regulators of
intracellular proteins. However, studying the changes in the organelle-specific expression …
intracellular proteins. However, studying the changes in the organelle-specific expression …
[HTML][HTML] Plasma hPG80 (Circulating Progastrin) as a Novel Prognostic Biomarker for early-stage breast cancer in a breast cancer cohort
Background Recurrence and metastases are still frequent outcomes after initial tumour
control in women diagnosed with breast cancer. Although therapies are selected based on …
control in women diagnosed with breast cancer. Although therapies are selected based on …
The E3 ligase HUWE1 increases the sensitivity of CRC to oxaliplatin through TOMM20 degradation
C Lee, SH Park, SK Yoon - Oncogene, 2024 - nature.com
Continuous administration of oxaliplatin, the most widely used first-line chemotherapy drug
for colorectal cancer (CRC), eventually leads to drug resistance. Increasing the sensitivity of …
for colorectal cancer (CRC), eventually leads to drug resistance. Increasing the sensitivity of …
Inhibition of microRNA-302c on stemness of colon cancer stem cells via the CARF/Wnt/β-catenin axis
Y Zhang, H Meng, K Guo - Digestive Diseases and Sciences, 2021 - Springer
Background Even though the relevance of microRNA (miR)-302c has been studied, little is
known about its involvement in colon cancer (CC). Aims Our aim here was to investigate the …
known about its involvement in colon cancer (CC). Aims Our aim here was to investigate the …
Novel N-(Heterocyclylphenyl)benzensulfonamide Sharing an Unreported Binding Site with T-Cell Factor 4 at the β-Catenin Armadillo Repeats Domain as an …
M Nalli, L Di Magno, Y Wen, X Liu… - ACS Pharmacology & …, 2023 - ACS Publications
Despite intensive efforts, no inhibitors of the Wnt/β-catenin signaling pathway have been
approved so far for the clinical treatment of cancer. We synthesized novel N …
approved so far for the clinical treatment of cancer. We synthesized novel N …